受强制性开放获取政策约束的文章 - José Valdez Ramalho Madruga了解详情
无法在其他位置公开访问的文章：3 篇
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
SMART Study Group*
Annals of internal medicine 149 (5), 289-299, 2008
强制性开放获取政策： US National Institutes of Health
Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study
L Monteiro Spindola Marins, T Silva Torres, PM Luz, RI Moreira, IC Leite, ...
International journal of STD & AIDS 32 (13), 1231-1241, 2021
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
Possible risk compensation, attitudes, and beliefs among Brazilian individuals potentially eligible for pre-exposure prophylaxis
LM Villela, VG Veloso, B Hoagland, NM Fernandes, EG Kallas, ...
International journal of STD & AIDS 32 (9), 806-815, 2021
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：15 篇
Cabotegravir for HIV prevention in cisgender men and transgender women
RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ...
New England Journal of Medicine 385 (7), 595-608, 2021
强制性开放获取政策： US National Institutes of Health
Raltegravir versus efavirenz regimens in treatment-naive HIV-1–infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses
JL Lennox, E DeJesus, DS Berger, A Lazzarin, RB Pollard, JVR Madruga, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (1), 39-48, 2010
强制性开放获取政策： US National Institutes of Health
High pre‐exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project
B Hoagland, RI Moreira, RB De Boni, EG Kallas, JV Madruga, ...
Journal of the International AIDS Society 20 (1), 21472, 2017
强制性开放获取政策： US National Institutes of Health
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
B Grinsztejn, N De Castro, V Arnold, VG Veloso, M Morgado, JH Pilotto, ...
The Lancet infectious diseases 14 (6), 459-467, 2014
强制性开放获取政策： US National Institutes of Health, UK Medical Research Council
Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled …
K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ...
The Lancet Infectious Diseases 22 (12), 1703-1715, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health, National …
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study
LMS Marins, TS Torres, IC Leite, RI Moreira, PM Luz, B Hoagland, ...
PLoS One 14 (8), e0221281, 2019
强制性开放获取政策： US National Institutes of Health
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial
J Suleiman, BS Zingman, RS Diaz, JV Ramalho Madruga, E DeJesus, ...
The Journal of infectious diseases 201 (4), 590-599, 2010
强制性开放获取政策： US National Institutes of Health
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru …
VG Veloso, CF Cáceres, B Hoagland, RI Moreira, H Vega-Ramírez, ...
The Lancet HIV 10 (2), e84-e96, 2023
强制性开放获取政策： World Health Organization
Rapid development of an integrated network infrastructure to conduct phase 3 COVID-19 vaccine trials
AJM Lora, JE Long, Y Huang, LR Baden, HM El Sahly, D Follmann, ...
JAMA network open 6 (1), e2251974-e2251974, 2023
强制性开放获取政策： Bill & Melinda Gates Foundation, US National Institutes of Health, Wellcome …
Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study
TS Torres, SLM Teixeira, B Hoagland, KA Konda, M Derrico, RI Moreira, ...
The Lancet Regional Health–Americas 28, 2023
强制性开放获取政策： US National Institutes of Health, World Health Organization
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the …
MA Marzinke, B Hanscom, Z Wang, SA Safren, C Psaros, D Donnell, ...
The Lancet HIV 10 (11), e703-e712, 2023
强制性开放获取政策： US National Institutes of Health
Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP …
KCS Petruccelli, DC Baía-da-Silva, F Val, MS Valões, N Cubas-Vega, ...
AIDS Research and Therapy 19 (1), 12, 2022
强制性开放获取政策： Fundação de Amparo à Pesquisa do Estado de São Paulo
Characteristics of REPRIEVE trial participants identifying across the transgender spectrum
LM Smeaton, EM Kileel, B Grinsztejn, EM Gardner, K Starr, ML Murry, ...
The Journal of Infectious Diseases 222 (Supplement_1), S31-S40, 2020
强制性开放获取政策： US National Institutes of Health
Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary …
MST Silva, TS Torres, C Coutinho, RI Moreira, I da Costa Leite, M Cunha, ...
The Lancet HIV 11 (10), e670-e679, 2024
强制性开放获取政策： World Health Organization
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial
DHS Tan, JM Raboud, L Szadkowski, B Grinsztejn, JV Madruga, ...
Journal of Antimicrobial Chemotherapy 74 (2), 480-488, 2019
强制性开放获取政策： Canadian Institutes of Health Research
出版信息和资助信息由计算机程序自动确定